经历了2021至2023年的持续三年低迷行情后，2024年以来港股市场已迈入"业绩+估值"双击的行情。 年初受大模型推出及AI商业化落地催化，中国资产重估行情启动，港股市场领衔上行，虽然四季度以 来港股市场有望承压，但年初至今的累计涨幅仍然亮眼，在全球主流市场指数中名列前茅，成功逆袭！ 恒生指数涨29.6%，其中的港股通标的更是"青出于蓝胜于蓝"，恒生港股通指数涨幅高达34.6%！ 今日，跟踪恒生港股通指数的恒生港股通ETF（520820）重磅上市！恒生港股通ETF（520820）囊括港 股重点板块稀缺资产，轻松布局港股互联网、创新药、新消费等优质龙头！ 数据截至2025.12.14 那么历经两年的估值修复后，港股市场在2026年又将有何表现呢？"指数投资"趋势下，又有哪些新工具 值得关注呢？ 【春山可望？2026年港股研判："乘势而上、迈向新高度"】 中信证券从多个维度剖析了港股市场2026年的配置价值，其中指出： 估值维度，当前港股仍是全球主要市场中的估值洼地，而计算当前的恒生指数ERP仍高达到5.7%。业绩 来看，当前Bloomberg一致预期显示恒生指数的2026E净利润同比增长8.5%。随着港股基本 ...

Core Viewpoint - The Shenzhen Stock Exchange and Shenzhen Securities Information Co., Ltd. announced a periodic adjustment of sample stocks for various indices, including the Shenzhen Component Index and ChiNext Index, effective December 15, 2025 [2][5]. Group 1: Index Adjustments - The Shenzhen Component Index will replace 17 sample stocks, including 7 from the main board and 10 from the ChiNext [5][6]. - The ChiNext Index will replace 8 sample stocks [5]. - The Shenzhen 100 Index will replace 7 sample stocks, with 4 from the main board and 3 from the ChiNext [5][7]. - The ChiNext 50 Index will replace 5 sample stocks [5]. Group 2: Industry Weightings - After the adjustments, the strategic emerging industry weight in the ChiNext Index will be 93%, while the ChiNext 50 Index will have a weight of 98%, with new generation information technology industries like AI, chips, and optical modules accounting for 45% [3][10]. - The Shenzhen 100 Index will see an increase in the weight of strategic emerging industries to 81%, with advanced manufacturing, digital economy, and green low-carbon sectors reaching 79% [10]. Group 3: Company Performance - The new sample companies in the ChiNext Index reported a 13% year-on-year increase in R&D expenses, with R&D expenses accounting for 5% of operating income, and 30 companies having an R&D intensity exceeding 10% [10]. - The new sample companies in the ChiNext Index experienced a 16% increase in operating income and a 24% increase in net profit year-on-year, with high-end equipment manufacturing and new energy sectors seeing net profit growth of 60% and 54%, respectively [10][11]. - The Shenzhen 100 Index companies have expanded their business internationally, with over 80% of sample companies operating in global supply chains, and overseas revenue showing a compound annual growth rate of 17% over the past three years [10].

来源：市场资讯 （来源：华泰证券策略研究） 目前市场下行空间可控但上行胜率尚未打开。港股情绪指标依然处于悲观区间，对应磨底阶段，情绪指 数走势与2024年11月类似。彼时情绪指标进入恐慌区间后，市场在2025年初迎来明显反弹，春节前后 DeepSeek催化下斜率放大。未来行情催化因素可能来自以下三点预期差：1）人民币升值：升值共识一 旦形成，资本流动或发生重要改变，可以类比今年欧洲市场；2）企业出海：市场依然担忧汇率升值和 出口高基数的影响，明年上半年中美关系依然处于温和期，出口韧性存在预期差；3）国内科技进展突 破，走出独立路径等。配置层面，短期关注资金面供需改善后的弹性品种如科技和医药，中期依然建议 成长+顺周期均衡，切换时间在二季度左右。全年维度看，个股相关性下降，去伪存真、自下而上的α 机会更加重要。 回顾：港股表现弱于A股，南向疲软、情绪基数和行业分化是主因 近期投资者普遍感受到港股表现相对疲软。10月至今MSCI香港/沪深300/恒生指数/纳斯达克金龙指数涨 跌幅分别为2.2%/-0.7%/-3.3%/-10.3%（均以港币计价），市场表现的表观差异并不如体感大。归因来 看： 1）10月初至今，作 ...

Fixed Income - The central economic work conference indicates a continuation of moderately loose monetary policy, suggesting that the current environment remains conducive to rate cuts and reserve requirement reductions [2][10] - The net financing scale of government bonds in 2026 is expected to slightly increase to around 14.5 trillion yuan, maintaining a stable issuance without significantly increasing supply pressure [10][12] - Social financing growth is projected to decline to approximately 7.3% in 2026, with a total increment of around 34 trillion yuan [10][12] - The bond market in 2026 may perform better than expected, with a potential policy interest rate cut of about 20 basis points anticipated [12][18] Pharmaceutical Industry - The collagen market shows significant potential, with animal-derived products having distinct advantages; Baijin Medical has three types of animal collagen products, with the first type recently approved [4][23] - The domestic market for animal-derived collagen in functional skincare and medical dressings is projected to reach 243 billion yuan by 2027 [23] - Baijin Medical is expected to submit 12 product registrations this year, with ongoing product launches anticipated, driving long-term growth [4][23] New Consumption - The CPI in November increased by 0.7%, primarily driven by rising food prices, marking the highest growth since March 2024 [28][29] - Lin Qingxuan, a high-end domestic skincare brand, reported a revenue of 1.052 billion yuan in the first half of 2025, reflecting a year-on-year growth of 98.3% [29][30] - The company has a strong offline presence with 554 stores, over 95% of which are located in shopping malls, positioning it as a leader among domestic and international high-end skincare brands [29][30] Metal New Materials - The Federal Reserve's recent rate cut of 25 basis points has led to an increase in copper prices, with expectations of a supply-demand shift towards a shortage in the future [32][33] - The lithium market is experiencing strong demand, with lithium prices entering an upward cycle due to ongoing inventory depletion [35] - Cobalt prices are expected to continue rising due to a tight supply situation, with recent changes in export regulations from the Democratic Republic of Congo impacting the market [36] North Exchange - The recent adjustments to the North Exchange 50 and specialized indices are expected to enhance the quality and scale of listed companies, with a focus on performance and strong growth potential [39][40] - The market is showing signs of stabilization, with an emphasis on identifying undervalued assets and companies in strong growth sectors such as commercial aerospace and AI [40]

Investment Rating - The report maintains an "Overweight" rating for the innovative pharmaceutical and medical device industry chain [3][5][6]. Core Insights - The report emphasizes the continuous recommendation of innovative drugs and medical devices, highlighting the high growth potential in the innovative pharmaceutical sector. It maintains "Overweight" ratings for companies such as Heng Rui Medicine, Hansoh Pharmaceutical, and others, indicating a potential for value re-evaluation [3][5]. - The report notes that the National Medical Insurance Administration has officially announced the 2025 medical insurance drug catalog, which includes 114 new drugs, 50 of which are first-class innovative drugs. This adjustment is seen as a validation of the support for innovation in the healthcare sector [3][5]. - The A-share pharmaceutical sector underperformed the broader market in the second week of December 2025, with the SW Pharmaceutical Biotechnology index declining by 1.0% compared to a 0.3% drop in the Shanghai Composite Index [7][18]. Summary by Sections Section 1: Continuous Recommendation of Innovative Drugs and Medical Devices - The report highlights the sustained recommendation of innovative drugs and medical devices, with a focus on companies that are expected to see performance growth and value re-evaluation [5][6]. Section 2: A-share Pharmaceutical Sector Performance - In the second week of December 2025, the A-share pharmaceutical sector's performance was weaker than the overall market, ranking 16th among the primary industries [7][18]. Section 3: Hong Kong and US Market Performance - The report indicates that the Hong Kong pharmaceutical sector also underperformed, while the US pharmaceutical sector showed stronger performance compared to the broader market [18].

Group 1: Theme Identification and Investment Strategies - The report aims to create a tool for theme investment by identifying theme opportunities through comprehensive screening of theme indices, allowing investment managers to focus on logical analysis and decision-making[3] - It emphasizes the construction of investable theme indices by mapping stocks and convertible bonds, providing sector classification and institutional holdings as auxiliary indicators[3] - The "right-side breakout" strategy captures signals for theme initiation, focusing on participating in the first wave of market movements, especially in bullish and volatile markets[4] Group 2: Performance Metrics and Backtesting Results - Backtesting results indicate that the right-side breakout strategy shows significant excess returns, particularly in bullish markets, with a holding period success rate of 69.6% and an average return of 5.1% in 2024[24] - The right-side trend strategy is designed to identify long-term upward trends, with a focus on timing exits, showing significant excess returns in both volatile and bullish markets[42] - The bottom stabilization and reversal strategies are aimed at identifying opportunities at low price levels, with backtesting showing a 50.5% success rate and an average return of 0.9% over five days from 2021 to 2024[51] Group 3: Institutional Participation and Risk Factors - As of Q3 2025, indices with a 2-5% fund holding ratio accounted for the highest proportion at 43.4%, with technology theme indices like optical modules having the highest fund holding at 20.4%[56] - The report highlights several risk factors, including historical performance not guaranteeing future results, industry uncertainties, and geopolitical risks[4]

Group 1 - The core point of the article is that the recent interest from foreign capital in the A-share market is driven by the Federal Reserve's interest rate cut, which has opened up new investment opportunities in China [1][3] - The Federal Reserve officially lowered the federal funds rate target range by 25 basis points to 3.5%-3.75% on December 10, 2025, in response to rising unemployment and signs of easing inflation [3] - The A-share market is currently seen as attractive due to its lower valuation compared to the US market, with a price-to-earnings ratio approximately 30% lower than that of US stocks [3] Group 2 - Foreign capital inflow into the Chinese stock market reached $50.6 billion in the first ten months of 2025, marking a new high in four years and more than tripling the total for 2024 [4] - As of the end of Q3 2025, northbound funds held a market value of A-shares amounting to 2.58 trillion yuan, with a cumulative increase of over 340 billion yuan in the first three quarters [4] - In September 2025, net inflow of northbound funds was $4.6 billion, the highest level since November 2024, indicating a growing confidence among foreign investors [4] Group 3 - The high-end manufacturing sector is a primary focus for foreign investment, supported by government policies aimed at promoting equipment upgrades and reducing financing costs [5] - In Q3 2025, foreign capital increased its holdings in the electronic industry by 1.82 billion shares, with a market value increase of 161.3 billion yuan, making it the most favored sector [5] - The Ministry of Industry and Information Technology plans to initiate a world-class advanced manufacturing cluster cultivation project by the end of 2024, further boosting foreign interest in this sector [5] Group 4 - The digital technology sector is another key area for foreign investment, driven by strong government support for digital economy initiatives [6] - In Q3 2025, foreign capital showed significant activity in the digital technology field, with substantial investments in semiconductor and communication sectors [7] - Northbound funds held a market value of 443.8 billion yuan in power equipment and 391.5 billion yuan in electronics, indicating a strong focus on technology-related industries [7] Group 5 - Satellite communication has emerged as a new investment focus for foreign capital, supported by government policies promoting the development of low-orbit satellite internet [8] - The Ministry of Industry and Information Technology has encouraged private enterprises to participate in the satellite communication industry, expanding application scenarios and investment opportunities [8] Group 6 - The consumer and pharmaceutical sectors are also attracting foreign investment due to their essential nature and government support for consumption upgrades [9] - The 2025 consumption upgrade policy includes subsidies for various household appliances, which is expected to stimulate market demand and attract foreign capital [9] - As of the end of Q3 2025, northbound funds held a market value of 183.9 billion yuan in the pharmaceutical and biotechnology sector, reflecting strong interest in stable demand and innovation [9]

Group 1: Primary Market - In the week from December 8 to December 12, 2025, a total of 369 credit bonds were issued, with a total issuance scale of 459.51 billion, representing a week-on-week increase of 35.34% [4] - Among the issued bonds, industrial bonds accounted for 174 issues with a scale of 186.50 billion, up 62.28% week-on-week, making up 40.59% of the total issuance [4] - City investment bonds totaled 149 issues with a scale of 88.81 billion, down 7.82% week-on-week, representing 19.33% of the total [4] - Financial bonds had 46 issues with a scale of 184.20 billion, up 43.60% week-on-week, comprising 40.09% of the total [4] - The average issuance term for credit bonds was 2.80 years, with industrial bonds averaging 2.36 years, city investment bonds 3.34 years, and financial bonds 2.48 years [4] - The overall average coupon rate for credit bonds was 2.24%, with industrial bonds at 2.19%, city investment bonds at 2.39%, and financial bonds at 1.96% [4] - Four credit bonds were canceled during the week [4] Group 2: Secondary Market - In terms of credit spreads, the largest increase for AAA-rated industries was in agriculture, forestry, animal husbandry, and fishery, which rose by 3.1 basis points, while the largest decrease was in pharmaceuticals and biology, down 4.2 basis points [5] - For AA+ rated industries, the largest increase was in electrical equipment, up 2.7 basis points, and the largest decrease was in building materials, down 12.7 basis points [5] - The largest increase in AA-rated industries was in machinery equipment, up 4.9 basis points, while the largest decrease was in public utilities, down 2.8 basis points [5] - For city investment bonds, the largest increase in AAA-rated credit spreads was in Yunnan, up 4.7 basis points, and the largest decrease was in Guangdong, down 3.7 basis points [5] - The largest increase in AA+ rated credit spreads was in Beijing, up 13 basis points, while the largest decrease was in Shaanxi, down 4.8 basis points [5] - The largest increase in AA-rated credit spreads was in Yunnan, up 4.9 basis points, and the largest decrease was in Shaanxi, down 9.8 basis points [5] Group 3: Trading Volume - The total trading volume of credit bonds was 1625.43 billion, reflecting a week-on-week increase of 36.58% [6] - The top three categories by trading volume were commercial bank bonds, corporate bonds, and medium-term notes [6] - Commercial bank bonds had a trading volume of 628.04 billion, up 60.23% week-on-week, accounting for 38.64% of the total trading volume [6] - Corporate bonds had a trading volume of 402.76 billion, up 10.55% week-on-week, making up 24.78% of the total [6] - Medium-term notes had a trading volume of 294.03 billion, up 23.12% week-on-week, representing 18.09% of the total [6]

Group 1 - The banking, steel, transportation, and real estate industries received significant attention from major funds, with the banking sector seeing a net inflow of 1.547 billion yuan [1] - The electronics, computer, communication, pharmaceutical, and defense industries experienced substantial net outflows, with the electronics sector facing nearly 18 billion yuan in sell-offs [1] Group 2 - Among individual stocks, Dongshan Precision received the highest net inflow of 1.508 billion yuan, with a weekly increase of 21.02% [1] - Shenghong Technology and BYD also saw notable net inflows of 1.379 billion yuan and 1.217 billion yuan, respectively [1] - In contrast, ZTE, Sungrow Power, and Tianfu Communication faced significant sell-offs, with net outflows of 5.317 billion yuan, 4.721 billion yuan, and 3.843 billion yuan, respectively [1]

Market Fund Flow Overview - Institutional funds have shown a net outflow from major indices, while retail funds have stabilized after a brief outflow, indicating a shift towards net inflow [3][10] - The net inflow rate difference between retail and institutional funds for the ChiNext index fell into negative territory from December 4 to 8, suggesting stronger institutional support for the index during this period [3][10] Market Capitalization and Valuation Style - Institutional funds are accelerating their outflow from high valuation indices and the CSI 300, reflecting a profit-taking tendency, while retail funds continue to flow into high valuation and large-cap styles [3][22] - The net inflow rate difference between retail and institutional funds has narrowed significantly after December 11, indicating a potential increase in institutional support for small-cap stocks [3][22] Major Industry Style - Both institutional and retail funds have consistently flowed into the consumer sector, while there is a divergence in the technology and cyclical manufacturing sectors [4][27] - Institutional outflows from the technology sector have increased again after a brief slowdown, while outflows from the cyclical sector have shown a converging trend [4][27] Primary Industry Fund Flow - In the upstream resources sector, there is a strong consensus on non-ferrous metals and basic chemicals, with institutional outflows from non-ferrous metals no longer significantly increasing [5][40] - The midstream materials and manufacturing sector has seen high trading activity in electrical equipment, while the downstream essential consumption sector has seen increased institutional investment in agriculture, forestry, animal husbandry, and fishery [5][40] Leverage Fund Situation - The margin trading balance remains high at approximately 2.51 trillion yuan, with the average collateral ratio slightly fluctuating [5][77] - The trading activity of margin financing has stabilized, with the trading volume accounting for 9.89% of total market transactions, indicating sustained market risk appetite [5][79] - The net buying amount of margin trading in the electronics sector has significantly increased, indicating a shift from bearish to bullish sentiment [5][84]